POZEN Names Gilda M. Thomas as Senior Vice President and General Counsel
Press Release Source: POZEN Inc.
POZEN Names Gilda M. Thomas as Senior Vice President and General Counsel
Wednesday January 10, 8:00 am ET
CHAPEL HILL, N.C.--(BUSINESS WIRE)--POZEN Inc. (NASDAQ: POZN - News), a pharmaceutical company focused primarily on products for the treatment of migraine, acute and chronic pain and other pain-related conditions, today announced the appointment of Gilda M. Thomas as Senior Vice President and General Counsel. Ms. Thomas will be responsible for all legal matters affecting the Company, its products, intellectual property, and employees.
Dr. John R. Plachetka, POZEN's Chairman, President and CEO said, "We believe Ms. Thomas will be a great asset to the POZEN team. Ms. Thomas has over 20 years of legal experience in the pharmaceutical industry. She brings a wealth of knowledge related to general business and commercial transactions, including intellectual property licensing and general corporate law."
Ms. Thomas was most recently employed at EMD Pharmaceuticals, Inc., an affiliate of Merck KGaA, Darmstadt, Germany as Vice President, General Counsel and Company Secretary. In this capacity, Ms. Thomas was responsible for overseeing and directing all legal matters for a fully-integrated start up pharmaceutical company. Prior to joining EMD in 2001, Ms. Thomas spent 14 years with Burroughs Wellcome Co., which merged into Glaxo Wellcome, Inc. While at Glaxo Wellcome, Ms. Thomas was Associate General Counsel responsible for the 13 member corporate section of the legal department.
Ms. Thomas received a J.D. (cum laude) from Harvard Law School, an M.S. from Simmons College and an A.B. from Wellesley College.
POZEN Names Gilda M. Thomas as Senior Vice President and General Counsel
Wednesday January 10, 8:00 am ET
CHAPEL HILL, N.C.--(BUSINESS WIRE)--POZEN Inc. (NASDAQ: POZN - News), a pharmaceutical company focused primarily on products for the treatment of migraine, acute and chronic pain and other pain-related conditions, today announced the appointment of Gilda M. Thomas as Senior Vice President and General Counsel. Ms. Thomas will be responsible for all legal matters affecting the Company, its products, intellectual property, and employees.
Dr. John R. Plachetka, POZEN's Chairman, President and CEO said, "We believe Ms. Thomas will be a great asset to the POZEN team. Ms. Thomas has over 20 years of legal experience in the pharmaceutical industry. She brings a wealth of knowledge related to general business and commercial transactions, including intellectual property licensing and general corporate law."
Ms. Thomas was most recently employed at EMD Pharmaceuticals, Inc., an affiliate of Merck KGaA, Darmstadt, Germany as Vice President, General Counsel and Company Secretary. In this capacity, Ms. Thomas was responsible for overseeing and directing all legal matters for a fully-integrated start up pharmaceutical company. Prior to joining EMD in 2001, Ms. Thomas spent 14 years with Burroughs Wellcome Co., which merged into Glaxo Wellcome, Inc. While at Glaxo Wellcome, Ms. Thomas was Associate General Counsel responsible for the 13 member corporate section of the legal department.
Ms. Thomas received a J.D. (cum laude) from Harvard Law School, an M.S. from Simmons College and an A.B. from Wellesley College.
posted by B at 7:52 PM
0 Comments:
Post a Comment
<< Home